Immunogenicity of SARS-CoV-2 trimetric spike protein associated to Poly(I:C) plus Alum
J. d. Santos, L. F. Cruz, A. M. d. Fonseca-Martins, D. O. Maciel, G. G. Perez, V. A. Roncaglia-Pereira, C. H. Dumard, F. H. Guedes da Silva, A. C. V. dos Santos, M. S. Leandro, J. R. M. Ferreira, K. G. Pinto, L. Conde, D. A. S. Rodrigues, M. V. M. Silva, R. G. F. Alvim, T. M. Lima, F. F. Marsili, D. P. B. d. Abreu, O. C. Ferreira, R. d. S. M. Borges, A. Tanuri, T. M. L. Souza, B. Rossi-Bergmann, A. M. Vale, , H. L. de Matos Guedes
Abstract
The SARS-CoV-2 pandemic has had a social and economic impact worldwide, and vaccination is an efficient strategy for diminishing those damages. New adjuvant formulations are required for the high vaccine demands, especially adjuvant formulations that induce a Th1 phenotype. Herein we assess a vaccination strategy using a combination of Alum and polyinosinic:polycytidylic acid (Poly(I:C)) adjuvants plus the SARS-CoV-2 spike protein in a prefusion trimeric conformation by an intradermal (ID) route. We found high levels of IgG anti-spike antibodies in the serum by enzyme linked immunosorbent assay (ELISA) and high neutralizing titers against SARS-CoV-2 in vitro by neutralization assay, after one or two boosts. By evaluating the production of IgG subtypes, as expected, we found that formulations containing Poly(I:C) induced IgG2a whereas Alum did not. The combination of these two adjuvants induced high levels of both IgG1 and IgG2a. In addition, cellular immune responses of CD4+ and CD8+ T cells producing interferon-gamma were equivalent, demonstrating that the Alum + Poly(I:C) combination supported a Th1 profile. Based on the high neutralizing titers, we evaluated B cells in the germinal centers, which are specific for receptor-binding domain (RBD) and spike, and observed that more positive B cells were induced upon the Alum + Poly(I:C) combination. Moreover, these B cells produced antibodies against both RBD and non-RBD sites. We also studied the impact of this vaccination preparation (spike protein with Alum + Poly(I:C)) in the lungs of mice challenged with inactivated SARS-CoV-2 virus. We found a production of IgG, but not IgA, and a reduction in neutrophil recruitment in the bronchoalveolar lavage fluid (BALF) of mice, suggesting that our immunization scheme reduced lung inflammation. Altogether, our data suggest that Alum and Poly(I:C) together is a possible adjuvant combination for vaccines against SARS-CoV-2 by the intradermal route.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Modified Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine
S. Jangra, J. De Vrieze, … M. Schotsaert·bioRxiv·Oct 23, 2020
- Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19
- Adjuvant selection for optimally balanced humoral and cellular immunity induced by SARS-CoV-2 Spike virosome vaccines
Marloes Grobben, Gius Kerster, … Rogier W. Sanders·bioRxiv·Jun 24, 2026
- Th2 and Th17-Associated Immunopathology Following SARS-CoV-2 Breakthrough Infection in Spike-vaccinated ACE2-humanized Mice
Tianyi Zhang, Nicholas Magazine, … Weishan Huang·Journal of Medical VirologyPeer-reviewed·Jan 1, 2024
- SARS-CoV-2 protein subunit vaccination elicits potent neutralizing antibody responses
M. Mandolesi, D. J. Sheward, … B. Murrell·bioRxiv·Jul 31, 2020
- Neutralising antibodies against the SARS-CoV-2 Delta variant induced by Alhydroxyquim-II-adjuvanted trimeric spike antigens
C. Counoupas, P. Pino, … J. A. Triccas·Microbiology SpectrumPeer-reviewed·Feb 23, 2022